Education
About Us
Working with TipRanks
Follow Us
CDC - AI Analysis
Top Page
VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC)
Rating:71Outperform
Price Target:
$73.00
Positive Factors
Strong Top Holdings
Several of the largest positions, particularly in the utilities sector, have delivered strong year-to-date performance, supporting the fund's overall returns.
Sector Diversification
The ETF is spread across multiple sectors, with significant exposure to defensive industries like utilities and consumer defensive, which can provide stability during market volatility.
Moderate Expense Ratio
The fund's expense ratio is reasonable compared to actively managed ETFs, allowing investors to keep more of their returns.
Negative Factors
High Geographic Concentration
The ETF is heavily focused on U.S. companies, offering limited exposure to international markets and global diversification.
Overweight in Utilities
A large portion of the portfolio is concentrated in the utilities sector, which could limit growth potential if this sector underperforms.
Slow Short-Term Performance
Recent one-month and three-month returns have been modest, suggesting the fund may struggle to gain momentum in the near term.
CDC vs. SPDR S&P 500 ETF (SPY)
AUM729.53M
RegionNorth America
Expense Ratio0.42%
Beta0.46
IssuerVictoryShares
Inception DateJul 02, 2014
Dividend Yield3.37%
Asset ClassEquity
Index TrackedNasdaq Victory U.S. Large Cap High Dividend 100 Long/Cash Volatility Weighted Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume20,095
30 Day Avg. Volume18,595
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
74.43Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering101
CDC Summary
The VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) is an investment fund that focuses on large U.S. companies, especially those offering steady dividends. It uses a unique strategy to reduce risk by avoiding highly volatile stocks, making it a good option for investors looking for stability and income. Some of its top holdings include well-known utility companies like Duke Energy and Southern Co. Investors might consider CDC for its potential to provide regular income while balancing risk. However, since it focuses heavily on sectors like utilities and consumer defensive, its performance may be impacted if these industries face challenges.
How much will it cost me?The CDC ETF has an expense ratio of 0.42%, which means you’ll pay $4.20 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, using a unique volatility-weighted strategy to balance income generation and risk reduction.
What would affect this ETF?The CDC ETF, with its focus on U.S. large-cap stocks and sectors like Utilities and Consumer Defensive, could benefit from stable economic conditions and increased demand for dividend-paying stocks, especially during periods of market uncertainty. However, rising interest rates or regulatory changes affecting utilities and energy companies may negatively impact its performance, as these sectors are sensitive to such factors. Additionally, shifts in investor sentiment away from defensive sectors toward growth-oriented areas could pose challenges for the fund.
CDC Top 10 Holdings
The CDC ETF is heavily tilted toward utilities and consumer defensive sectors, with names like Evergy and WEC Energy Group leading the charge. These steady performers have benefited from stable financials and strategic investments in renewable energy, providing a solid foundation for the fund. However, some holdings, such as CMS Energy and DTE Energy, have shown mixed results, with growth initiatives offset by cash flow challenges and high leverage. With its focus on U.S. large-cap stocks, the fund offers a reliable income stream but may lack the growth potential of more diversified or tech-heavy portfolios.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Evergy | 1.72% | $12.35M | $17.89B | 28.64% | 68 Neutral | |
| WEC Energy Group | 1.62% | $11.68M | $36.24B | 17.87% | 70 Outperform | |
| CMS Energy | 1.57% | $11.30M | $21.91B | 5.17% | 69 Neutral | |
| Duke Energy | 1.56% | $11.22M | $97.37B | 8.62% | 75 Outperform | |
| American Electric Power | 1.55% | $11.17M | $65.24B | 23.43% | 72 Outperform | |
| Southern Co | 1.52% | $10.96M | $104.58B | 4.44% | 65 Neutral | |
| DTE Energy | 1.51% | $10.89M | $28.66B | 11.14% | 67 Neutral | |
| Xcel Energy | 1.51% | $10.87M | $48.25B | 22.12% | 72 Outperform | |
| Coca-Cola | 1.51% | $10.86M | $296.73B | 5.62% | 78 Outperform | |
| Alliant Energy | 1.49% | $10.76M | $17.46B | 13.22% | 71 Outperform |
CDC Technical Analysis
Neutral
―
Price Trends
65.91
Negative
64.97
Positive
63.60
Positive
Market Momentum
-0.09
Positive
41.35
Neutral
9.81
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CDC, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 66.04, equal to the 50-day MA of 65.91, and equal to the 200-day MA of 63.60, indicating a neutral trend. The MACD of -0.09 indicates Positive momentum. The RSI at 41.35 is Neutral, neither overbought nor oversold. The STOCH value of 9.81 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CDC.
CDC Peer Comparison
Comparison Results
Performance Comparison
CDC
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
65.23
3.62
5.88%
SEIM
SEI Enhanced U.S. Large Cap Momentum Factor ETF
―
―
―
VOTE
Engine No. 1 Transform 500 ETF
―
―
―
ONEY
SPDR Russell 1000 Yield Focus ETF
―
―
―
AVLC
Avantis U.S. Large Cap Equity ETF
―
―
―
DSPY
Tema S&P 500 Historical Weight ETF Strategy
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents